You are not logged in
Login
Create Account
Meetings
Help
Contact Us
Visit our Twitter
Visit our LinkedIn
GI CONNECT meeting during ESMO 2024 - Pre-Meeting Survey - 14-09-2024
If you wish to view the details for the meeting, then please click the button.
Back to the Meeting Details
Please only respond to the questions applicable to your speciality
Name
*
Email Address
*
Please indicate which of the following GI oncology areas you specialise in: colorectal / rectal cancer, gastric / gastroesophageal cancer, pancreatic cancer or other GI cancer
*
Within the field of colorectal cancer, what are the current areas of greatest educational need?
What do you consider were the main new developments and/or data coming to light over the last 12 months in colorectal cancer?
What do you anticipate will be the most important news or developments within the area of colorectal cancer in the next 12 months?
Which biomarkers do you commonly test for in colorectal cancer patients? Select all that apply:
KRAS
NRAS
BRAF
MSI (microsatellite instability)
HER2
Others
If you selected the "others" option in the previous question, please specify
Which biomarker-directed therapies do you commonly prescribe for colorectal cancer patients? Please provide generic name if possible:
At what stage of the colorectal cancer patient journey do you typically conduct biomarker testing? Select all that apply:
At initial diagnosis
Before starting first-line therapy
Before starting second-line therapy
Upon disease progression
Other
If you selected the "other" option in the previous question, please specify
Within the field of gastroesophageal cancer, what are the current areas of greatest educational need?
What do you consider were the main new developments and/or data coming to light over the last 12 months in gastroesophageal cancer?
What do you anticipate will be the most important news or developments within the area of gastroesophageal cancer in the next 12 months?
Within the field of pancreatic cancer, what are the current areas of greatest educational need?
What do you consider were the main new developments and/or data coming to light over the last 12 months in pancreatic cancer?
What do you anticipate will be the most important news or developments within the area of pancreatic cancer in the next 12 months
Based on your answers to the questions above, please recommend up to 3 educational topics that could be a focus of educational activities for GI CONNECT
*
Are there any other specific agenda items you wish to see discussed in the forthcoming meeting?
Submit
COR2ED develops and implements high quality Independent Medical Education programmes to help improve the health of patients globally.
Bodenackerstrasse 17
4103 Bottmingen
Switzerland
Products
Webinars
Meetings
On Demand
SUPPORT
HELP
CONTACT US
Disclaimer: The material and content contained in the website engage.cor2ed.com is for healthcare professionals only. Although every effort is made to ensure that the material within this website is accurate and timely, it is provided for informational and educational purposes only. The information provided is not intended as a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country.
© Copyright 2021 | All Rights Reserved
Cookies
Privacy Policy
map-marker
sign-in
user-plus
linkedin
facebook
pinterest
youtube
rss
twitter
instagram
facebook-blank
rss-blank
linkedin-blank
pinterest
youtube
twitter
instagram
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept
View Cookie Policy
